Canine gastrinoma: A case study and literature review of therapeutic options

New Zealand Veterinary Journal

Volumn 54, Issue 5, 2006, Pages 242-247

  Hughes, S M ^a  

^a Taranaki Veterinary Centre   (New Zealand)

Author keywords

Canine; Gastric hyperacidity; Gastrin; Gastrinoma; Pancreatic tumours; Proton pump inhibitors; Zollinger Ellison syndrome

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIULCER AGENT; GASTRIN; OMEPRAZOLE; RANITIDINE; SUCRALFATE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CASE REPORT; DOG; DOG DISEASE; FATALITY; FEMALE; GASTRINOMA; METASTASIS; PANCREAS TUMOR; PATHOLOGY; TREATMENT OUTCOME;

ANIMALS; ANTI-ULCER AGENTS; ANTINEOPLASTIC AGENTS; DOG DISEASES; DOGS; FATAL OUTCOME; FEMALE; GASTRINOMA; GASTRINS; NEOPLASM METASTASIS; OMEPRAZOLE; PANCREATIC NEOPLASMS; RANITIDINE; SUCRALFATE; TREATMENT OUTCOME;

CANIS FAMILIARIS;

EID: 33750289466     PISSN: 00480169     EISSN: 11760710     Source Type: Journal    
DOI: 10.1080/00480169.2006.36705     Document Type: Article

References (74)

1. Altschul M, Simpson KW Dykes NL, Mauldin EA, Reubi JC, Cummings JF. Evaluation of somatostatin analogues for the detection and treatment of gastrinoma in a dog. Journal of Small Animal Practice 38, 286–91, 1997
2. Anonymous. Losec; Astrazeneca Ltd, 1999. New Ethicals Compendium. 7th Edtn. Pp 1056–8. Adis International Ltd, Auckland, NZ, 2000
3. Arnold R. Therapeutic strategies in the management of endocrine GEP tumours. European Journal of Clinical Investigation 20 (Supplement 1), 82–90, 1990
4. Arnold R, Frank M, Kajdan U. Management of gastroenteropancreatic endocrine tumours: the place of somatostatin analogues. Digestion 55 (Supplement 3), 107–13, 1994
5. Arnold R, Simon B, Wied M. Treatment of neuroendocrine GEP tumours with somatostatin analogues: a review. Digestion 62 (Supplement 1), 84–91, 2000
6. Bersenas AM, Matthews KA, Allen DG, Conlon PD. Effects of ranitidine, famotidine, pantoprazole and omeprazole on intragastric pH in dogs. American Journal of Veterinary Research 66, 425–31, 2005
7. Bilchik AJ, Sarantou T, Fushag LJ, Giuliano AE, Ramming KP. Cryosurgical palliation of metastatic neuroendocrine tumours resistant to conventional therapy. Surgery 122, 1040–7, 1997
8. Bornman PC, Radebold K. Changing therapy for gastrinoma. Hepatic, Pancreatic and Biliary Surgery 10, 411–3, 1998
9. Breitschwerdt EB, Turk JR, Turnwald GH, Davenport DJ, Hedlund CS, Carakostas MC. Hypergastrinemia in canine gastrointestinal disease. Journal of the American Animal Hospital Association 22, 585–92, 1986
10. Brooks D, Watson GL. Omeprazole in a dog with gastrinoma. Journal of Veterinary Internal Medicine 11, 379–81, 1997
11. Desir B, Poitras P. Oral pantoprazole for acid suppression in the treatment of patients with Zollinger-Ellison syndrome. Canadian Journal of Gastroenterology 15, 795–8, 2001
12. Dhillo WS, Jayasena CN, Lewis CJ, Martin NM, Tang KC, Meeran K, Todd JF. Plasma gastrin measurement cannot be used to diagnose a gastrinoma in patients on either proton pump inhibitors or histamine type-2 receptor antagonists. Annals of Clinical Biochemistry 43, 153–5, 2006
13. Donow C, Pipeleers-Marichal M, Schroder S, Stamm B, Heitz PU, Kloppel Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy. Cancer 68, 1329–34, 1991
14. Drazner FH. Canine gastrinoma: A condition analogous to the Zollinger-Ellison syndrome in man. California Veterinarian 11, 6–11, 1981
15. Eiseman B, Maynard RM. An non-insulin producing islet cell adenoma associated with progressive peptic ulceration (the Zollinger-Ellison syndrome). Gastroenterology 31, 296–304, 1956
16. Ellison EC, Carey LC, Sparks J, O’Dorisio TM, Mekhjian HS, Fromkes JJ, Caldwell JH, Thomas FB. Early surgical treatment of gastrinoma. American Journal of Medicine 29 (5B), 17–24, 1987
17. English RV, Breitschwerdt EB, Grindem CB, Thrall DE, Gainsburg LA. Zollinger-Ellison syndrome and myelofibrosis in a dog. Journal of the American Veterinary Medical Association 192, 1430–4, 1988
18. Feldman EC, Nelson RW. Gastrinoma, glucagonoma, and other APUDomas. Canine and Feline Endocrinology and Reproduction. 2nd Edtn. Pp 442–53. WB Saunders Co, Philadelphia, USA, 1987
19. Frank M, Klose KJ, Wied M, Ishaque N, Schade-Brittinger C, Arnold R. Combination therapy with octreotide and alpha-interferon: effect on tumour growth in metastatic endocrine gastroenteropancreatic tumours. American Journal of Gastroenterology 94, 1381–7, 1999
20. Fukushima U, Sato M, Okano S, Aramaki Y, Ito H, Yoshioka K, Oyamada T, Uechi M. A case of gastrinoma in a Shih-Tzu dog. Journal of Veterinary Medical Science 66, 311–3, 2004a
21. Fukushima R, Ichikawa K, Hirabayashi M, Yamagami T, Koyama H, Hirose Uchino T. A case of canine gastrinoma. Journal of Veterinary Medical Science 66, 993–5, 2004b
22. Gaztambide S, Vazquez JA. Short-and long-term effect of a long-acting somatostatin analogue, lanreotide (SR-L) on metastatic gastrinoma. Journal of Endocrinological Investigation 22, 144–6, 1999
23. Gibril F, Jensen RT. Zollinger-Ellison syndrome revisited: diagnosis, biologic markers, associated inherited disorders, and acid hypersecretion. Current Gastroenterology Reports 6, 454–63, 2004
24. Gottwald T, Koveker G, Busing M, Lauchart W, Becker HD. Diagnosis and management of metastatic gastrinoma by multimodality treatment including liver transplantation: report of a case. Surgery Today 28, 551–8, 1998
25. Green RA, Gartrell CL. Gastrinoma: A retrospective study of four cases (1985-1995). Journal of the American Animal Hospital Association 33, 524-7,1997
26. Guyton AC, Hall JE. Secretory functions of the alimentary tract. In: Guyton AC, Hall JE (eds). Textbook of Medical Physiology. 9th Edtn. Pp 815–32. WB Saunders Co, Philadelphia, USA, 1996
27. Happe RP, van der Gaag I, Lamers CBHW van Toorenburg J, Rehfeld JF, Larsson LI. Zollinger-Ellison syndrome in three dogs. Veterinary Pathology 17, 177–86, 1980
28. Hattori Y, Imamura M, Tobe T. Gastrin release from antral G cells stimulated with secretin. American Journal of Gastroenterology 87, 195–200, 1992
29. Hayden DW, Henson MS. Gastrin-secreting pancreatic endocrine tumour in a dog (putative Zollinger-Ellison syndrome). Journal of Veterinary Diagnostic Investigation 9, 100–3, 1997
30. Hayes JR, O’Connell N, O’Neill T, Fennelly JJ, Weir DG. Successful treatment of a malignant gastrinoma with streptozotocin. Gut 17, 285–8, 1976
31. Hellman P, Ladjevardi S, Skogseid B, Akerstrom G, Elvin A. Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumours. World Journal of Surgery 26, 1052–6, 2002
32. Herrmann ME, Ciesla MC, Chejfec G, DeJong SA, Yong SL. Primary nodal gastrinomas. Archives of Pathology and Laboratory Medicine 124, 832–5, 2000
33. Hoenerhoff M, Kiupel M. Concurrent gastrinoma and somatostatinoma in a 10-year-old Portuguese Water Dog. Journal of Comparative Pathology 130, 313–8, 2004
34. Hung PD, Schubert ML, Mihas AA. Zollinger-Ellison syndrome. Current Treatment Options in Gastroenterology 6, 163–70, 2003
35. Jensen RT, Fraker DL. Zollinger-Ellison syndrome: Advances in treatment of gastric hypersecretion and the gastrinoma. Journal of the American Medical Association 271, 1429–30, 1994
36. Jones BR, Nicholls MR, Badman R. Peptic ulceration in a dog associated with an islet cell carcinoma of the pancreas and an elevated plasma gastrin level. Journal of Small Animal Practice 17, 593–8, 1976
37. Kisker O, Bastian D, Bartsch D, Nies C, Rothmund M. Localisation, malignant potential, and surgical management of gastrinomas. World Journal of Surgery 22, 651–8, 1998
38. Konturek SJ, Konturek PC, Bielanski W, Lorens K, Sito E, Konturek JW, Kwiecien S, Bobrzynski A, Pawlik T, Karez D, Areny H, Stachura T. Case presentation of gastrinoma combined with gastric carcinoid with the longest survival record -Zollinger-Ellison syndrome: pathophysiology, diagnosis and therapy. Medical Science Monitor 8, 43–59, 2002
39. Leimer M, Kurtaran A, Smith-Jones P, Raderer M, Havlik, Angelberger P, Vorbeck F, Niederle B, Herold C, Virgolini I. Response to treatment with yttrium 90-DOTA-lanreotide of a patient with metastatic gastrinoma. Journal of Nuclear Medicine 39, 2090–4, 1998
40. Li ML, Norton JA. Gastrinoma. Current Treatment Options in Oncology 2, 33746,2001
41. Livraghi T, Vettori C, Lazzaroni S. Liver metastases: results of percutaneous ethanol injection in 14 patients. Radiology 179, 709–12, 1991
42. Lothrop CD. Medical treatment of neuroendocrine tumours of the gastroenteropancreatic system with somatostatin. In: Kirk RW (ed). Current Veterinary Therapy X. Pp 1020–4. WB Saunders Co, Philadelphia, USA, 1989
43. Lurye JC, Behrend EN. Endocrine tumours. Veterinary Clinics of North America: Small Animal Practice 31, 1083–110, 2001
44. Melvin WS, Johnson JA, Sparks J, Innes JT, Ellison EC. Long-term prognosis of Zollinger-Ellison syndrome in multiple endocrine neoplasia. Surgery 114, 1183–8, 1993
45. Mignon M, Cadiot G. Diagnostic and therapeutic criteria in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Journal of Internal Medicine 243, 489–94, 1998
46. Mignon M, Cadiot G, Marmuse JP, Lewin MJ. Is gastrinoma a medical disease? Yale Journal of Biology and Medicine 69, 289–300, 1996
47. Norton JA. Gastrinoma: advances in localization and treatment. Surgical Oncology Clinics of North America 7, 845–61, 1998
48. Norton JA, Jensen RT. Current surgical management of Zollinger-Ellison syndrome (ZES) in patients without multiple endocrine neoplasia-type 1 (MEN1). Surgical Oncology 12, 145–51, 2003
49. Norton JA, Alexander HR, Fraker DL, Venzon DJ, Gibril F, Jensen RT. Possible primary lymph node gastrinoma: occurrence, natural history, and predictive factors: a prospective study. Annals of Surgery 237, 650–7, 2003
50. O’Byrne KJ, Goggins MG, McDonald GS, Daly PA, Kelleher DP, Weir DG. A metastatic neuroendocrine anaplastic small cell tumor in a patient with multiple endocrine neoplasia type 1 syndrome. Assessment of disease status and response to doxorubicin, cyclophosphamide, etoposide chemotherapy through scintigraphic imaging with 111In-pentetreotide. Cancer 74, 2374–8, 1994
51. Ohshio G, Hosotani R, Imamura M, Sakahara H, Ochi J, Kubota N. Gastrinoma with multiple liver metastases: effectiveness of dacarbazine (DTIC) therapy. Journal of Hepatobiliary and Pancreatic Surgery 5, 339–43, 1998
52. Perry LJ, Stuart K, Stokes KR, Clouse ME. Hepatic arterial chemoembolisation for metastatic neuroendocrine tumors. Surgery 116, 1111–7, 1994
53. Pipeleers-Marichal M, Donow C, Heitz PU, Kloppel G. Pathological aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type 1. World Journal of Surgery 17, 481–8, 1993
54. Quatrini M, Castoldi L, Rossi G, Cesana BM, Peracchi M, Bardella MT. A follow-up study of patients with Zollinger-Ellison syndrome in the period 1966—2002: Effects of surgical and medical treatments on long-term survival. Journal of Clinical Gastroenterology 39, 376–80, 2005
55. Ricci S, Antonuzzo A, Galli L, Orlandini C, Ferdeghini M, Boni G, Roncella M, Mosca F, Conte PF. Long-acting depot lanreotide in the treatment of patients with advanced neuroendocrine tumours. American Journal of Clinical Oncology 23, 412–5, 2000
56. Rothmund M, Stinner B, Arnold R. Endocrine pancreatic carcinoma. European Journal of Surgical Oncology 17, 191–9, 1991
57. Rousseaux CG. Ultrastructure of a canine gastrinoma. Journal of Comparative Pathology 97, 605–7, 1987
58. Ruffner BW Jr. Chemotherapy for malignant Zollinger-Ellison tumours: successful treatment with streptozotocin and fluorouracil. Archives of Internal Medicine 136, 1032–4, 1976
59. Ruszniewski P, Hochlaf S, Rougier P, Mignon M. Intravenous chemotherapy with streptozotocin and 5 fluorouracil for hepatic metastases of Zollinger-Ellison syndrome. A prospective multicenter study in 21 patients. Gastroenterologie Clinique et Biologique 15, 393–8, 1991
60. Ruszniewski P, Rougier P, Roache A, Legmann P, Sibert A, Hochlaf S, Ychou M, Mignon M. Hepatic arterial chemoembolisation in patients with liver metastases of endocrine tumours. A prospective phase II study in 24 patients. Cancer 71, 2624–30, 1993
61. Saijo F, Naito H, Funayama K, Shibata C, Hashimoto A, Kitayama T, Nagao M, Matsuno S, Sasaki I. Octreotide in control of multiple liver metastases from gastrinoma. Journal of Gastroenterology 38, 905–8, 2003
62. Schubert ML. Gastric secretion. Current Opinion in Gastroenterology 19, 519–25, 2003
63. Schubert ML, Shamburek RD. Control of acid secretion. Gastroenterology Clinics of North America 19, 1–25, 1990
64. Shearman DJ. A new form of antihistamine-the H2-receptor antagonist. Medical Journal of Australia 26, 1005–9, 1976
65. Simpson KW. Gastrinoma in dogs. In: Kirk RW, Bonagura JD (eds). Current Veterinary Therapy XIII. Pp 617–21. WB Saunders, Philadelphia, USA, 2000
66. Simpson KW, Dykes NL. Diagnosis and treatment of gastrinoma. Seminars in Veterinary Medicine and Surgery (Small Animal) 12, 274–81, 1997
67. Stabile BE, Morrow DJ, Passaro E Jr. The gastrinoma triangle: operative implications. American Journal of Surgery 147, 25–31, 1984
68. Strombeck DR, Guilford WG. Integration of gastrointestinal functions. Small Animal Gastroenterology. 2nd Edtn. Pp 1–14. Stonegate Publishing Company, Davis, California, USA, 1990a
69. Strombeck DR, Guilford WG. Acute gastritis. Small Animal Gastroenterology. 2nd Edtn. Pp 191–207. Stonegate Publishing Company, Davis, California, USA, 1990b
70. Vergine M, Pozzo S, Pogliani E, Rondena M, Roccabianca P, Bertazzolo W. Common bile duct obstruction due to a duodenal gastrinoma in a dog. Veterinary Journal 170, 141–3, 2005
71. Vinik AI, Tsai S, Moattari AR, Cheung P. Somatostatin analogue (SMS 201995) in patients with gastrinomas. Surgery 104, 834–42, 1988
72. Virgolini I, Traub-Weidinger T, Decristoforo C. Nuclear medicine in the detection and management of pancreatic islet-cell tumours. Best Practice and Research Clinical Endocrinology and Metabolism 19, 213–27, 2005
73. Zerbe CA. Islet cell tumours secreting insulin pancreatic polypeptide, gastrin, or glucagon. In: Kirk RW, Bonagura JD (eds). Current Veterinary Therapy XI. Pp 368–75. WB Saunders, Philadelphia, USA, 1992
74. Zollinger RM, Ellison EH. Primary peptic ulceration of the jejunum associated with islet cell tumours of the pancreas. Annals of Surgery 142, 709–28, 1955